Can I Take Reishi Mushroom with Azelaic Acid?

What Azelaic Acid Actually Does in the Skin

Azelaic acid is a naturally occurring dicarboxylic acid derived from grains. Prescription-strength formulations at 15% (Finacea gel) and 20% (Azelex cream) work through three distinct mechanisms: they inhibit the enzyme tyrosinase to reduce pigmentation, they suppress Cutibacterium acnes growth through antimicrobial action, and they reduce keratinocyte hyperproliferation responsible for comedones and the papules of rosacea.

The drug's safety profile in women is notably good. Because topical application results in only about 4% systemic absorption, the plasma concentrations reached are far below those that would affect systemic pathways. This low bioavailability is the single most important fact when you evaluate any supplement interaction with azelaic acid: the drug simply does not circulate at meaningful levels.

Why Women Use It More Than Men

Women are prescribed azelaic acid at substantially higher rates than men, for reasons tied directly to female physiology. Rosacea affects women at roughly twice the rate it affects men, and hormonal fluctuations across the menstrual cycle amplify both redness and papulopustular flares. Melasma, which is driven by estrogen and progesterone stimulating melanocytes, affects women in up to 90% of cases. PCOS-related hyperandrogenism triggers inflammatory acne on the lower face and jawline, and azelaic acid's dual antimicrobial and anti-inflammatory action makes it a frequent dermatology choice for this population.

Post-inflammatory hyperpigmentation from any of these conditions also responds to azelaic acid's tyrosinase inhibition, making it a workhorse across the reproductive years, pregnancy, and into perimenopause.

How the Menstrual Cycle Changes Your Skin Response

Estrogen in the follicular phase tends to thicken the stratum corneum and improve barrier function, which means absorption of topical agents may be slightly lower mid-cycle. Progesterone in the luteal phase increases sebum output and may worsen the inflammatory environment that azelaic acid is countering. Clinically, women with hormonally driven acne or rosacea often notice their skin is most reactive in the week before menstruation, and they may need to apply their azelaic acid more consistently during that window rather than reducing use.

No published pharmacokinetic studies have measured azelaic acid absorption across cycle phases specifically. That is an honest evidence gap.

What Reishi Mushroom Does in the Body

Reishi (Ganoderma lucidum) is one of the most studied medicinal mushrooms, and it works through mechanisms that are genuinely complex.

Immune Modulation: The Core Mechanism

Reishi's bioactive compounds, primarily polysaccharides (beta-glucans) and triterpenes (ganoderic acids), interact with pattern-recognition receptors on immune cells. The result is broadly described as immune modulation rather than simple immune stimulation. In practice, reishi may upregulate natural killer cell activity while also demonstrating anti-inflammatory effects through inhibition of NF-kB signaling. A 2012 Cochrane-supported systematic review found no clear benefit of reishi for cancer treatment outcomes, but noted immune parameter changes in trial participants, confirming biological activity.

Anticoagulant-Adjacent Effects on Platelets

This is where women combining reishi with any prescription medication should pay closer attention. Ganoderic acids in reishi inhibit platelet aggregation in vitro, and several animal studies have demonstrated reduced thrombus formation. A 2005 in vitro study found that reishi triterpenes inhibited both arachidonic acid-induced and ADP-induced platelet aggregation, with dose-dependent effects.

This does not mean reishi is a drug-level anticoagulant. Human data on clinically meaningful bleeding risk from reishi alone is limited. The concern rises when reishi is combined with actual anticoagulants (warfarin, apixaban, rivaroxaban), NSAIDs, aspirin, or omega-3 supplements at high doses.

Liver Metabolism Considerations

Reishi may weakly inhibit some cytochrome P450 enzymes, specifically CYP3A4 and CYP2E1, based on in vitro data. Since azelaic acid is not primarily metabolized through CYP enzymes (it undergoes mitochondrial beta-oxidation), this potential interaction is largely irrelevant for the azelaic acid combination specifically. However, if you take hormonal contraceptives, some antidepressants, or thyroid medication alongside both reishi and azelaic acid, the CYP inhibition question becomes worth raising with your prescriber.

The Actual Interaction Between Reishi and Azelaic Acid

Here is the direct answer: there is no documented pharmacokinetic interaction between topical azelaic acid and oral reishi mushroom in the published literature as of January 2025. The Natural Medicines Database (formerly Natural Standard) classifies this combination as having insufficient evidence to rate an interaction level, which is distinct from saying the interaction is safe.

The reasons an interaction is unlikely at the pharmacokinetic level are:

• Azelaic acid is not metabolized by CYP enzymes that reishi may weakly inhibit
• Topical azelaic acid reaches plasma levels too low to compete meaningfully with reishi's systemic effects
• Azelaic acid does not affect platelet aggregation or coagulation pathways

The reasons for caution at the pharmacodynamic level are narrower but real:

• If you are using azelaic acid as part of a broader acne or rosacea regimen that includes a blood-thinning medication or high-dose fish oil, adding reishi increases the aggregate anticoagulant burden
• Reishi's immune modulation, while generally gentle, is poorly studied in women with autoimmune-driven rosacea (a distinct phenotype from vascular rosacea)
• Women with PCOS who use metformin alongside azelaic acid and reishi should note that metformin affects CYP2C8, a minor metabolic pathway for azelaic acid, though the clinical significance of this triple combination is unknown

The clearest framework for evaluating this combination: think of the interaction risk not as drug-supplement but as supplement-to-broader-regimen. Azelaic acid itself is not the concern. Your full medication list is.

Life-Stage Guide: When This Combination Matters Most

Reproductive Years and PCOS

Women with PCOS commonly turn to reishi for its adaptogenic and potential insulin-sensitizing properties alongside azelaic acid for jawline acne. PCOS affects 8 to 13% of women of reproductive age, and managing its skin manifestations while supporting adrenal stress response is a reasonable dual goal. The combination appears low-risk in otherwise healthy women not taking anticoagulants. Discuss with your prescribing clinician if you are on metformin, spironolactone, or oral contraceptives.

Spironolactone in particular warrants a note: it has mild anticoagulant-adjacent effects on its own, and adding reishi's platelet effects on top of spironolactone plus a systemic blood-thinning supplement would be three layers of additive risk.

Trying to Conceive

Azelaic acid is generally considered acceptable to continue while trying to conceive given its local application and low systemic absorption. Reishi, though, should be approached with caution in this window. Animal studies have raised questions about reishi's effects on reproductive hormone signaling, though human fertility data is essentially absent. The conservative recommendation is to pause reishi supplementation while actively trying to conceive until more human data exists.

Perimenopause and Menopause

Perimenopausal skin changes are significant. Falling estrogen reduces collagen density and alters barrier function, which can worsen rosacea and slow post-inflammatory hyperpigmentation clearance. Azelaic acid use often continues or increases in this life stage.

Reishi is popular among perimenopausal women for sleep support, immune function, and stress adaptation. The immune-modulating property of reishi may theoretically help with the neurogenic inflammation component of rosacea, though no published trial has tested this directly. That is an honest evidence gap worth naming.

Women in this stage are also more likely to be on cardiovascular medications, and the anticoagulant-adjacent effect of reishi deserves explicit review with a prescriber.

Pregnancy and Lactation Safety

This section is required for any drug article on WomanRx, and it matters especially here because azelaic acid is one of the few topical dermatology agents with meaningful pregnancy safety data.

Azelaic Acid in Pregnancy

Azelaic acid carries an FDA Pregnancy Category B designation, meaning animal studies showed no fetal risk and no adequate human controlled studies have shown harm. It is listed among the topical agents considered acceptable for use in pregnancy by dermatologists managing melasma and acne when the clinical benefit justifies use. ACOG's guidance on dermatologic conditions in pregnancy does not specifically restrict azelaic acid, and most dermatology-obstetrics consensus statements categorize it as low risk in the second and third trimesters, with more caution applied to the first trimester simply due to limited data rather than demonstrated harm.

Melasma is directly driven by the surge in estrogen and progesterone during pregnancy. Azelaic acid 20% has been studied as a pregnancy-safe alternative to hydroquinone (which is avoided in pregnancy) for managing gestational melasma.

Lactation

Systemic absorption of topical azelaic acid is low enough that meaningful transfer into breast milk is considered unlikely. The manufacturer advises caution and suggests avoiding application to the nipple or areola area. LactMed lists azelaic acid as likely compatible with breastfeeding given its low systemic levels, though controlled lactation studies have not been conducted.

Reishi in Pregnancy and Lactation

Reishi mushroom should not be taken during pregnancy. No adequate human safety data exists. Animal studies using high-dose reishi extracts have shown effects on uterine tissue in some models, and the immunomodulatory activity of reishi is poorly characterized in the context of pregnancy immune tolerance. The conservative and correct recommendation is to stop reishi before conception and avoid it through lactation until more data is available.

If you are pregnant and using azelaic acid for melasma or acne, that combination stands on its own reasonable safety profile. Simply do not add reishi to the mix during pregnancy or while breastfeeding.

Who This Combination Is Right For, and Who Should Think Twice

Lower Concern: You Are Probably Fine Combining These If

• You are a non-pregnant adult using prescription azelaic acid 15% or 20% for rosacea, hormonal acne, or melasma
• You are not taking anticoagulant medications, high-dose aspirin, or prescription blood thinners
• You are not taking immunosuppressant medications (for autoimmune conditions)
• Your reishi dose is within typical supplement ranges (1 to 3 grams of dried mushroom extract daily)
• You have discussed your full supplement list with your prescriber

Higher Concern: Review With Your Clinician First If

• You are pregnant or breastfeeding (reishi should be paused)
• You are trying to conceive (pause reishi; continue azelaic acid as directed)
• You take warfarin, apixaban, rivaroxaban, or clopidogrel
• You take high-dose omega-3 supplements (>2 grams EPA/DHA daily) or daily aspirin
• You have an autoimmune condition (lupus, Hashimoto's, rheumatoid arthritis) where immune modulation carries unpredictable effects
• You are perimenopausal and on cardiovascular or anticoagulant medication
• You have chronic liver disease (reishi has rare hepatotoxicity reports at high doses; one case series documented liver injury with powdered reishi in patients with underlying liver conditions)

Practical Monitoring and What to Do If You Are Already Taking Both

If you are already using azelaic acid and reishi together and have not had problems, that is consistent with the low direct interaction risk between these two agents. The steps worth taking:

Tell your prescriber. The interaction concern is not azelaic acid itself but your broader regimen. Your provider cannot assess your full anticoagulant burden without knowing about reishi.

Watch for bruising or bleeding. If you develop unusual bruising, prolonged bleeding from minor cuts, or heavy menstrual periods that are new, stop reishi and report this. Heavy menstrual bleeding in women of reproductive age is a particularly relevant signal because platelet-aggregation inhibition can worsen menorrhagia.

Time your reishi dose. Since any interaction here is pharmacodynamic rather than pharmacokinetic, dose separation from azelaic acid is not the relevant strategy. Instead, separate reishi from other supplements or medications with anticoagulant properties, and take it consistently at the same time each day so any effects are predictable.

Do not apply reishi topically alongside azelaic acid without dermatologist input. Some skincare brands now include mushroom extracts in topical formulations. Combining an active ingredient like azelaic acid with immune-modulating compounds in the same formulation layer has not been studied, and the vehicle interactions could affect acid stability.

What the Evidence Gap Looks Like

Women have been underrepresented in supplement-drug interaction trials across the board, and this topic is no exception. The existing data on reishi's anticoagulant-adjacent effects comes primarily from in vitro and animal studies; the two small human trials that exist enrolled predominantly male participants. A 2020 review of Ganoderma lucidum clinical trials found methodological quality was low across available studies, with inadequate reporting of sex-stratified outcomes.

Azelaic acid pharmacokinetic studies similarly enrolled small samples without cycle-phase stratification or hormonal status documentation.

What this means for you practically: the absence of a documented interaction does not guarantee safety, but it also reflects a real absence of research rather than evidence of harm. The interaction risk model here is built on mechanism reasoning rather than observed clinical events.

How Skin Conditions Change Across Female Life Stages

A brief reference guide because the conditions driving azelaic acid use shift considerably by life stage:

| Life Stage | Common Indication for Azelaic Acid | Hormonal Driver | |---|---|---| | Reproductive years | Hormonal acne, PCOS-related comedones | Androgens, mid-cycle estrogen drop | | Pregnancy | Melasma, acne (hydroquinone-free option) | Estrogen, progesterone surge | | Postpartum | Post-inflammatory hyperpigmentation | Estrogen withdrawal | | Perimenopause | Rosacea, adult acne, hyperpigmentation | Estrogen decline, cortisol dysregulation | | Post-menopause | Rosacea, dyschromia | Low estrogen, vascular changes |

Reishi's appeal similarly shifts by life stage: it is used for stress support and immune function in the reproductive years, for sleep and immune maintenance in perimenopause, and for cardiovascular and cognitive support in post-menopause. The life-stage overlap where both agents are most commonly used together is perimenopause, which is also the stage with the most complex medication backgrounds. That overlap makes a full prescriber review most important precisely in this group.